Canadian Bioceutical Corporation Enters Into Strategic Partnership

TORONTO – The Canadian Bioceutical Corporation (CSE:BCC) (OTC:CBICF) today announced the signing of a strategic partnership agreement with MJardin, a professional cannabis management company that provides turnkey cultivation, processing and related services.

Under the terms of the strategic partnership, MJardin will provide turnkey cultivation, processing and project management services for several of BCC’s licensed facilities, including ones in Massachusetts and Nevada, once the acquisition of the latter has been completed.

“This partnership adds important operational capacity and know-how to the BCC platform that will help us accelerate growth as we expand our footprint,” said Beth Stavola, President of U.S. operations for BCC. “Based on MJardin’s track record at other sites under their management, we believe the partnership will further improve operational efficiencies, contributing to profitability growth at our facilities.”

“MJardin has built considerable brand equity within the cannabis sector, which we intend to leverage as we expand our wholesale operations,” added Scott Boyes, CEO of BCC. “Additionally, the partnership opens up new avenues to explore expansion opportunities in states we are not yet active in.”

“As BCC continues to execute well on its aggressive expansion strategy, MJardin will bring its proven operational and management expertise to a number of the licensed facilities supported and/or operated by the Company to provide the highest quality cannabis and operational efficiencies,” said James Lowe, MJardin’s Co-Founder and Chief Cultivation Officer.

MJardin has an exceptional track record in operating cannabis facilities, and currently manages over 30 licensed facilities with a footprint in 13 U.S. states and 2 countries. MJardin has produced well over 60,000 kilograms of consistently high quality finished product since the Company’s inception in 2014, making it one of the largest cultivators of legal cannabis in the world.

BCC, through its wholly owned subsidiary CGX Life Sciences, Inc. provides management services, staffing, procurement, advisory, financial, real estate rental, logistics, and administrative services to two medicinal cannabis enterprises in Arizona (third under development), and one in Massachusetts. BCC also is in the process of acquiring outright a cultivation, production, and wholesale cannabis business in Las Vegas, Nevada, which is anticipated to be completed shortly, as well as a fourth operation in Arizona and up to three dispensaries in Maryland.

MJardin’s exceptional track record in improving operational efficiencies is due largely to its approach to R&D. MJardin’s R&D department has access to the most up-to-date horticultural technology through various collaborations with institutions of higher learning, horticultural technology companies, agricultural suppliers, lighting companies, and third-party cultivation management companies. These relationships also provide access to confidential information on developmental products, prototypes, and technologies that have not yet been released to the market.

Source: Technical 420